The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

University Hospitals research suggests the Decipher tumor score could help doctors personalize treatment decisions for men ...

Please provide your email address to receive an email when new articles are posted on . A genetic test that identifies the PAM50 biomarker predicted which patients with recurrent prostate cancer would ...

IntroductionThe discomfort caused by a mismatch between the sex assigned at birth and one's internal sense of gender (gender ...

In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...

The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances.

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...

Stress management, regular exercise, quality sleep, and a balanced diet are cornerstones of maintaining hormonal balance. Your hormones — including testosterone, insulin, cortisol, and more — affect ...